Live news related to GENFIT stock (FR0004163111): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Genfit announces a research collaboration with EVerZom to develop exosome-based technologies in the field of regeneration, particularly for ACLF.
Genfit has announced its intention to voluntarily withdraw its American Depositary Shares from the Nasdaq Global Select Market.
Genfit has announced progress in its pipeline regarding ACLF at The Liver Meeting 2025 hosted by AASLD.